Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, Boyadzhiev H, Melchardt T, Hölscher AS, Schultze-Florey CR, Abdelhafez A, Velazquez GF, Ossami Saidy A, Lesan V, Schnetzke U, Kerkhoff A, Bacher U, Ghandili S, Aydilek E, Gebauer N, Weber T, Wulf GG, Glass B, Thurner L, Heidel FH, Schmid C, Viardot A, Hänel M, Dietrich S, Pabst T, Ayuk FA, von Tresckow B, Chapuy B, Pott C, Müller F, Lenz G. Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma. Blood Adv. 2025 Apr 16:bloodadvances.2024015719. doi: 10.1182/bloodadvances.2024015719. Epub ahead of print. PMID: 40238938

Nguyen HA, Doerfler J, Buentzel J, Keinki C, Huebner J. Assessing iIndications for herbal medicinal products: a comparative analysis of EMA monographs and database records. BMC Complement Med Ther. 2025 Apr 9;25(1):130. doi: 10.1186/s12906-025-04852-8. PMID: 40205417

Hochhaus A, Kim DW, Cortes JE, Sasaki K, Mauro MJ, Hughes TP, Breccia M, Talpaz M, Minami H, Goh YT, DeAngelo DJ, Lang F, Ottmann O, Heinrich MC, Gomez Garcia de Soria V, le Coutre P, Sanchez-Olle G, Cao M, Pognan N, Kapoor S, Hoch M, Rea D. Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results. Leukemia. 2025 Apr 9. doi: 10.1038/s41375-025-02578-7. Epub ahead of print. PMID: 40204892

Cortes JE, Lang F, Rea D, Hochhaus A, Breccia M, Goh YT, Heinrich MC, Hughes TP, Janssen JJWM, le Coutre P, Minami H, Sasaki K, DeAngelo DJ, Sanchez-Olle G, Pognan N, Cao M, Hoch M, Mauro MJ. Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results. Leukemia. 2025 Apr 9. doi: 10.1038/s41375-025-02592-9. Epub ahead of print. PMID: 40204896

Heyder C, Büntzel J, Boyadzhiev H, Stegmaier P, Zomorodbakhsch B, Heißner K, Stoll C, von Weikersthal LF, Czekay J, Rudolph I, Hübner J. Does anxiety influence the use of complementary or alternative medicine among cancer patients? J Cancer Res Clin Oncol. 2025 Mar 26;151(3):123. doi: 10.1007/s00432-025-06173-2. PMID: 4013367

Ruhnke L, Bill M, Zukunft S, Eckardt JN, Schäfer S, Stasik S, Hanoun M, Schroeder T, Fransecky L, Steffen B, Krause SW, Scholl S, Hochhaus A, Sauer T, Kraus S, Schäfer-Eckart K, Kaufmann M, Jost E, Brümmendorf T, Schliemann C, Mikesch JH, Krug U, Hänel M, Morgner A, Schaich M, Neubauer A, Repp R, Niemann D, Seggewiss-Bernhardt R, Meinhardt A, Kullmer J, Kaiser U, Blau W, Kiani A, Grigoleit GU, Giagounidis A, Wurm AA, Altmann H, Middeke JM, Schetelig J, Müller-Tidow C, Stölzel F, Baldus CD, Platzbecker U, Serve H, Bornhäuser M, Thiede C, Röllig C. Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia. Blood Adv. 2025 Mar 25;9(6):1392-1404. doi: 10.1182/bloodadvances.2024013304. PMID: 39504561

Fosså, A., Molin, D., Bröckelmann, P.J., Schneider, G., Schnetzke, U., Linderoth, J., Kamper, P.M.H., Leppä, S.M., Meissner, J., Schaub, V., Lia, K., Fuchs, M., Borchmann, P. and Böll, B. (2025), Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial. HemaSphere, 9: e70099. https://doi.org/10.1002/hem3.70099

Zibrova D, Ernst T, Hochhaus A, Heller R. The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling. Mol Cell Biochem. 2025 Mar;480(3):1627-1643. doi: 10.1007/s11010-024-05070-5. Epub 2024 Jul 15. PMID: 39009935; PMCID: PMC11842422

Jahns L, Hübner J, Mensger C, Mathies V. A Neutropenic Diet in Haemato-Oncological Patients Receiving High-Dose Therapy and Hematopoietic Stem Cell Transplantation: A Systematic Review. Nutrients. 2025; 17(5):768. https://doi.org/10.3390/nu17050768

Ruhe S, Orawa H, Huebner J, Büntzel J. Hidden Resources for Cancer Patients - Interactions between spirituality, religiosity and selected factors influencing patient's self-care. Oncology. 2025 Feb 3:1-27. doi: 10.1159/000543312. Epub ahead of print. PMID: 39900005

Nicole Erickson, Virpi Sulosaari, Erin Stella Sullivan, Alessandro Laviano, Annemieke van Ginkel-Res, Wineke Remijnse, Joost Wesseling, Ute Koepcke, Nina Weber, Jutta Huebner, Viktoria Mathies, Sebastian Theurich, Theres Fey: Nutrition Care in Cancer: An Overlooked Part of Patient-Centered Care, Seminars in Oncology Nursing, Volume 41, Issue 1, 2025, 151799, ISSN 0749-2081, https://doi.org/10.1016/j.soncn.2024.151799

Fleischmann M, Jentzsch M, Brioli A, Eisele F, Frietsch JJ, Eigendorff F, Tober R, Schrenk KG, Hammersen JF, Yomade O, Hilgendorf I, Hochhaus A, Scholl S, Schnetzke U. Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia. Ann Hematol. 2024 Oct 25. doi: 10.1007/s00277-024-06048-5. Epub ahead of print. Erratum in: Ann Hematol. 2024 Dec;103(12):6061. doi: 10.1007/s00277-024-06095-y. PMID: 39453477

Rötzer, I., Frank, M., von Grundherr, J. et al. Ernährungstherapeutische Besonderheiten bei Patienten mit einem Magenkarzinom. Onkologie 31, 206–212 (2025). https://doi.org/10.1007/s00761-024-01633-9

Gale RP, Hochhaus A. Mpox in people with haematological cancers. Leukemia. 2025 Feb;39(2):275. doi: 10.1038/s41375-024-02465-7. Epub 2024 Dec 13. PMID: 39672828

Röllig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Hänel M, Noppeney R, Hanoun M, Kaufmann M, Weinbergerova B, Schäfer-Eckart K, Sauer T, Neubauer A, Burchert A, Baldus CD, Mertová J, Jost E, Niemann D, Novák J, Krause SW, Scholl S, Hochhaus A, Held G, Szotkowski T, Rank A, Schmid C, Fransecky L, Kayser S, Schaich M, Kramer M, Fiebig F, Haake A, Schetelig J, Middeke JM, Stölzel F, Platzbecker U, Thiede C, Müller-Tidow C, Berdel WE, Ehninger G, Mayer J, Serve H, Bornhäuser M. Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia. J Clin Oncol. 2025 Jan;43(1):65-74. doi: 10.1200/JCO.24.00235. Epub 2024 Sep 16. PMID: 39284116

Xiong L, Beyer D, Liu N, Lehmann T, Neugebauer S, Schaeuble S, Sommerfeld O, Ernst P, Svensson CM, Nietzsche S, Scholl S, Bruns T, Gaßler N, Gräler MH, Figge MT, Panagiotou G, Bauer M, Press AT. Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models. Pharmacol Res. 2025 Jan 4;212:107581. doi: 10.1016/j.phrs.2025.107581. Epub ahead of print. PMID: 39761839

Meren SS, Josfeld L, Bahlmann JC, Fischer von Weikersthal L, Männle H, Huebner J. Feelings of guilt among cancer patients and the usage of complementary or alternative medicine - A cross-sectional survey. Palliat Support Care. 2025 Jan 20;23:e21. doi: 10.1017/S1478951524001718. PMID: 39829247

Erickson N, Sulosaari V, Sullivan ES, Laviano A, van Ginkel-Res A, Remijnse W, Wesseling J, Koepcke U, Weber N, Huebner J, Mathies V, Theurich S, Fey T. Nutrition Care in Cancer: An Overlooked Part of Patient-Centered Care. Semin Oncol Nurs. 2025 Jan 10:151799. doi: 10.1016/j.soncn.2024.151799. Epub ahead of print. PMID: 39799089